# Breathe BioMedical Adds Duke University as Second Site in Breast Cancer Breath Test Trial

> clinical trial · REPORTED · 2025-06-17

Breathe BioMedical announced on June 17, 2025, the launch of Duke University as the second site in its large multi-center observational study developing a non-invasive breath test for early breast cancer detection in women with dense breast tissue, as an adjunct to mammography. The study's Co-Principal Investigators are from Mayo Clinic Florida.

About Breathe BioMedical: Breathe BioMedical develops a breath analytics platform using proprietary spectrometry and machine-learning algorithms to detect disease biomarkers in exhaled breath, targeting early-stage breast cancer detection as its lead indication.

- Company: Breathe Biomedical
- Sector: diagnostics
- Primary source: https://finance.yahoo.com/news/breathe-biomedical-launches-second-multi-110000169.html

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.